Division of Gastroenterology & Hepatology
Leadership
Name:
David Kastenberg, MD
Position:
- Chief, Division of Gastroenterology & Hepatology
- J. Edward Berk Professor of Medicine
Contact
Name:
Division of Gastroenterology & Hepatology
132 South 10th Street
Main Building, Suite 480
Philadelphia, PA 19107
Contact Number(s):
- 215-955-5112
- 215-923-3447 (fax)
Research Activities
Current Clinical Trials
The Division of Gastroenterology & Hepatology conducts a number of clinical trials in various aspects of digestive and liver diseases. For more information on any of these trials, please contact Cynthia Miller, RN, at 215-955-8108.
Learn more about registered studies by visiting clinicaltrials.gov.
3rd Annual Fellows Research Symposium (May 2026) Winners Announced:
- Most Creative Research- Nick Noverati, MD
- Most Patient Friendly Research- Justin Robbins, MD
- Most Innovative Research- Pankhuri Jha, MD
- Most Likely to Improve Quality of Care Research- Akash Patel, DO
- Best Presentation Overall- Madison Force, MD
Publications
- Air Cholangiography versus Contrast Cholangiography in Patients with Hilar Biliary Obstruction: A Systematic Review and Meta-Analysis
- From Efficacy to Implementation: Integrating Palliative Care after the PAL-LIVER Trial
- A randomized study of digital versus genetic counselor return of actionable genetic research results to biobank participants (RESPECT3 study)
- Interstitial fluid N-glycans serve as a proxy for serum biomarker discovery in a pilot study
- Validation of next‑generation sequencing‑derived circulating mRNA variants as potential diagnostic tools in hepatocellular carcinoma and cholangiocarcinoma
- Outcomes of peroral endoscopic myotomy in patients with cirrhosis: a multicenter experience
- Risk factors for bleeding after endoscopic retrograde cholangiopancreatography: a systematic review and meta-analysis
- WFUMB Liver Ultrasound Fusion Imaging Technical Review and Position Statement: Focus on CT/MRI-Based Fusion
- Trends in Incidence and Prevalence of Acute Pancreatitis in the United States: A Population-Based Analysis from 1995 to 2024
- Urinary cell-free DNA as a noninvasive liquid biopsy for hepatocellular carcinoma
- Balanced Fluid or 0.9% Saline in Children Treated for Septic Shock
- Stress ulcer prophylaxis in mechanically ventilated patients
- Measuring quality of life in advanced chronic liver disease with FACT-Hep: Findings from the PAL LIVER trial
- Immune reconstitution and tolerance-inducing therapies as promising therapeutic approaches in multiple sclerosis
- Mapping drivers of life expectancy change in Asia from 1990 to 2023
- Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848
- Heading Toward a Different Future: The Microbiome, Dysbiosis, Microbial Translocation, and Beyond
- Artificial intelligence with mucosal exposure devices versus artificial intelligence alone in detection of colorectal adenomas: a systematic review and meta-analysis
- Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes
- Accessibility and harmonization of biochemical tests for diagnosis and monitoring of Porphyrias in the United States: Recommendations by members of the American Porphyrias Expert Collaborative (APEX)